170 related articles for article (PubMed ID: 22238670)
21. Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per se.
Endesfelder S; Krahn A; Kreuzer KA; Lass U; Schmidt CA; Jahrmarkt C; von Moers A; Speer A
J Mol Med (Berl); 2000; 78(10):569-74. PubMed ID: 11199330
[TBL] [Abstract][Full Text] [Related]
22. Total Absence of Dystrophin Expression Exacerbates Ectopic Myofiber Calcification and Fibrosis and Alters Macrophage Infiltration Patterns.
Young CNJ; Gosselin MRF; Rumney R; Oksiejuk A; Chira N; Bozycki L; Matryba P; Łukasiewicz K; Kao AP; Dunlop J; Robson SC; Zabłocki K; Górecki DC
Am J Pathol; 2020 Jan; 190(1):190-205. PubMed ID: 31726040
[TBL] [Abstract][Full Text] [Related]
23. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy.
Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D
Hum Mol Genet; 2013 Sep; 22(18):3720-9. PubMed ID: 23681067
[TBL] [Abstract][Full Text] [Related]
24. Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin.
Banks GB; Combs AC; Chamberlain JR; Chamberlain JS
Hum Mol Genet; 2008 Dec; 17(24):3975-86. PubMed ID: 18799475
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice.
Zhang Y; Long C; Li H; McAnally JR; Baskin KK; Shelton JM; Bassel-Duby R; Olson EN
Sci Adv; 2017 Apr; 3(4):e1602814. PubMed ID: 28439558
[TBL] [Abstract][Full Text] [Related]
28. rAAV6-microdystrophin rescues aberrant Golgi complex organization in mdx skeletal muscles.
Percival JM; Gregorevic P; Odom GL; Banks GB; Chamberlain JS; Froehner SC
Traffic; 2007 Oct; 8(10):1424-39. PubMed ID: 17714427
[TBL] [Abstract][Full Text] [Related]
29. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
30. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
Koo T; Malerba A; Athanasopoulos T; Trollet C; Boldrin L; Ferry A; Popplewell L; Foster H; Foster K; Dickson G
Hum Gene Ther; 2011 Nov; 22(11):1379-88. PubMed ID: 21453126
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
32. Electrical impedance myography detects dystrophin-related muscle changes in mdx mice.
Hiyoshi T; Zhao F; Baba R; Hirakawa T; Kuboki R; Suzuki K; Tomimatsu Y; O'Donnell P; Han S; Zach N; Nakashima M
Skelet Muscle; 2023 Nov; 13(1):19. PubMed ID: 37980539
[TBL] [Abstract][Full Text] [Related]
33. Low dystrophin levels in heart can delay heart failure in mdx mice.
van Putten M; van der Pijl EM; Hulsker M; Verhaart IE; Nadarajah VD; van der Weerd L; Aartsma-Rus A
J Mol Cell Cardiol; 2014 Apr; 69():17-23. PubMed ID: 24486194
[TBL] [Abstract][Full Text] [Related]
34. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.
Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T
Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830
[TBL] [Abstract][Full Text] [Related]
35. Altered biomechanical properties of carotid arteries in two mouse models of muscular dystrophy.
Dye WW; Gleason RL; Wilson E; Humphrey JD
J Appl Physiol (1985); 2007 Aug; 103(2):664-72. PubMed ID: 17525297
[TBL] [Abstract][Full Text] [Related]
36. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins.
Bonuccelli G; Sotgia F; Schubert W; Park DS; Frank PG; Woodman SE; Insabato L; Cammer M; Minetti C; Lisanti MP
Am J Pathol; 2003 Oct; 163(4):1663-75. PubMed ID: 14507673
[TBL] [Abstract][Full Text] [Related]
37. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
38. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.
Krämer R; Lochmüller H; Abicht A; Rüdel R; Brinkmeier H
Neuromuscul Disord; 1998 Dec; 8(8):542-50. PubMed ID: 10093060
[TBL] [Abstract][Full Text] [Related]
39. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
[TBL] [Abstract][Full Text] [Related]
40. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
